Literature DB >> 2867334

C-III DNA restriction fragment length polymorphism and myocardial infarction.

G A Ferns, J Stocks, D J Galton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2867334     DOI： 10.1016/s0140-6736(86)90740-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  DNA polymorphism and the study of disease associations.

Authors:  D N Cooper; J F Clayton
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

2.  Haplotypes of the human apoprotein AI-CIII-AIV gene cluster in coronary atherosclerosis.

Authors:  G A Ferns; D J Galton
Journal:  Hum Genet       Date:  1986-07       Impact factor: 4.132

3.  Linkage disequilibrium of three polymorphic RFLP markers in the apolipoprotein AI-CIII gene cluster on chromosome 11.

Authors:  O Marasco; F Melina; E Mele; B Quaresima; A Zingone; E Focarelli; E Picciotti; M L Martelli; L Fotino; M F Vigna
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

4.  Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD.

Authors:  S Chhabra; R Narang; R Lakshmy; S Vasisht; D P Agarwal; L M Srivastava; S C Manchanda; N Das
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

5.  A DNA polymorphism of the apoprotein AII gene in hypertriglyceridaemia.

Authors:  G A Ferns; C S Shelley; J Stocks; A Rees; H Paul; F Baralle; D J Galton
Journal:  Hum Genet       Date:  1986-11       Impact factor: 4.132

6.  Association of a DNA polymorphism in the apolipoprotein C-III gene with diverse hyperlipidaemic phenotypes.

Authors:  H E Henderson; S V Landon; J Michie; G M Berger
Journal:  Hum Genet       Date:  1987-01       Impact factor: 4.132
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.